Form 4 for RMD ResMed|
Accepted 2022-11-22 00:00:00 ET · period of report 2022-11-21 · accession 0001127602-22-026264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-22 | 2022-11-21 | RMD | BLAISE LUCILE | Pres, Sleep, RC Business | F - Tax | $224.40 | -267 | 6,552 | -4% | -$59.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-21 | F | D | 78 | $224.40 | 6,627 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2022-11-21 | F | D | 114 | $224.40 | 6,705 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2022-11-21 | F | D | 75 | $224.40 | 6,552 | D | — | — |